News | Magnetic Resonance Imaging (MRI) | February 28, 2020

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

February 28, 2020 — MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24-27, 2020 in Thessaloniki, Greece. 

Fabrice Chaumard, MR Solution’s sales and marketing director commented: “Our very latest compact scanners with multi-modality imaging techniques will be on display at EMIM. These systems offer better performance at a very competitive cost and do not require helium top-ups. We will be welcoming visitors to Booth #104 to show off our state of the art range of MRI/PET/SPECT/CT technology with interchangeable cradles to speed-up and minimise handling.”

MR Solutions’ preclinical MRI systems offer superior soft tissue contrast and molecular imaging capability for great visualisation, quantification and translational studies. Because the molecular imaging systems are compact they do not need a reinforced concrete floor, Faraday cage, liquid helium, or special height requirement for the room. They can also be installed next to other scanners and other sensitive equipment as their stray magnetic field is a few centimetres compared to metres with liquid helium cooled systems.

MR Solutions’ MRI and CT technology can be combined with PET or SPECT imaging modules for either simultaneous or sequential imaging (dependent on the chosen configuration).

The EMIM is an annual event organized by the European Society for Molecular Imaging. The programme allows researchers to discuss and share knowledge within the molecular imaging community and to take a look at emerging technologies.

MR Solutions works closely with leading academic institutions across the world to be at the cutting edge of performance. Its own research, development and assembly of the scanners is carried out in the UK with 99% of their orders being exported to the world’s leading academic and research institutions.

MR Solutions’ dry magnet, preclinical MRI systems have been recognized with prestigious award wins including three Queen’s Awards for Enterprise – for innovation in 2016 and 2019 and for international trade in 2017.

For more information: www.mrsolutions.com


Related Content

News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
Subscribe Now